EpitoGenesis Corporation is established to develop prophylactic and therapeutic vaccines as well as anti-infectives and anti-cancer therapeutics. Our focus is on developing safe and effective adjuvants and delivery systems for direct applications on the first lines of defense, i.e. the skin or mucosal membranes, all of which are covered by epithelial cells.
EpitoGenesis Inc. is co-founded by Dr. Michael Vajdy, a Mucosal Immunologist, with 18 years of experience in Immunology and vaccine research gained from academia and the biotechnology industry.
Ms. Shore Padrah is co-founder of EpitoGenesis Corporation. Ms. Padrah holds a Batchelor of Ars degree in International Business Administration and Accounting. She has several years of experience from the financial and healthcare industries.
We are currenlty in the process of setting up partnerships and in-licensing agreements as well as filing patents on immunopotentiators.
For further information about possible partnerships, in- or out-licensing, collaborations, or consulting please contact Dr. Michael Vajdy:
by email: vajdy@epitogenesis.com,
by phone:
Welcomme to epitogenesis.com
For further information about possible partnerships, in- or out-licensing, collaborations, or consulting please contact Dr. Michael Vajdy:
by email: vajdy@epitogenesis.com,
by phone:
| EpitoGenesis Corporation is established to develop prophylactic and therapeutic vaccines as well as anti-infectives and anti-canser therapeutics. Our focus is on develping safe and effective adjuvants and delivery systems for direct applications on the first lines of defence, i.e. the skin or mucosal membranes, all of which are covered by epithelial cells. |